Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors
Non-Hodgkin lymphomas comprise a heterogenous group of disorders which differ in biology. Although response rates are high in some groups, relapsed disease can be difficult to treat, and newer approaches are needed for this patient population. It is increasingly apparent that the immune system plays...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2020-01-01
|
| Серія: | Journal of Immunology Research |
| Онлайн доступ: | http://dx.doi.org/10.1155/2020/8820377 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|